NAD for Health: Opportunities & Challenges 2026
This international conference explores a central question in aging research: can manipulation of nicotinamide adenine dinucleotide (NAD⁺) metabolism enhance human healthspan and prevent age-related diseases?
March 23-25, 2026 the conference will bring together leading experts in NAD⁺ biology, aging, and clinical medicine – as well as industry partners – at the Royal Danish Academy of Science and Letters in Copenhagen.
The program will feature thematic sessions on topics such as
- neurodegenerative diseases
- cardiometabolic health
- strategies for healthy aging.
These will be complemented by plenary discussions on translational challenges, clinical trial design, and emerging directions in NAD⁺ research. The conference will actively engage early-career researchers through short talks, posters, and networking activities.
Industry partners, including Niagen Bioscience, Blue Helix, and Sironax, will contribute to discussions on accelerating clinical applications.
Registration and costs
You must register to show your interest in participating no later than: January 16, 2026.
Application is free and should include CV and abstract detailing the work and the motivation to participate.
Read more and register for the conference
If you are selected to participate, there will be a participation fee (GST included).
- Academia: DKK 750
- Industry: DKK 2000
Organizers
- Jonas Treebak (University of Copenhagen)
- Vilhelm Bohr (University of Copenhagen)
- Danica Chen (UC Berkeley)
- Marie Migaud (University of South Alabama)
- Joseph Baur (University of Pennsylvania)